Key facts
- This page summarizes Rory B. Riggs's Form 4 filing for FIBROGEN INC (FGEN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 May 2021, 19:08.
Rory B. Riggs - 26 May 2021 Form 4 Insider Report for FIBROGEN INC (FGEN)
- Reporting relationship
- Director
- Issuer ticker
- FGEN
- Reported as of
- 26 May 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 May 2021, 19:08:40 UTC
- Prior SEC filing
- 11 May 2021
- Next SEC filing
- 04 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dorothy Pacini, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rory B. Riggs filed Form 4 for FIBROGEN INC (FGEN) on 28 May 2021.
Change
- Previous filing in this sequence was filed on 11 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FGEN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,700
- Change %
- +1.2%
- Price
- $0.000000
- Shares after
- 395,750
- Date
- 26 May 2021
- Ownership
- Direct
- Footnotes
- F1
FGEN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 605,713
- Date
- 26 May 2021
- Ownership
- See footnote
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FGEN
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +7,800
- Change %
- Price
- $0.000000
- Shares after
- 7,800
- Date
- 26 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,800
- Exercise price
- $20.86
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.
Footnote F2
Shares are held by New Ventures I, LLC. The reporting person is Managing Member of New Ventures I, LLC and has voting and investment control with respect to the shares held by New Ventures I, LLC.
Footnote F3
Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date.